Amway (Malaysia) Holdings Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amway (Malaysia) Holdings Berhad with three other
drug stores in Asia:
China Pioneer Pharma Holdings Ltd
of CHINA
(2019
sales of 1.32 billion Chinese Renmimbi [US$203.17 million]
of which 75%
was Products sold via the provision of compr),
Vietnam Pharmaceutical Corp
of VIETNAM
(5.69 trillion Vietnamese Dong [US$247.08 million]
), and
Millennium Pharmacon International Tbk PT
which is
based in INDONESIA
(2.73 trillion Indonesian Rupiahs [US$194.42 million]
).
Sales Analysis.
Amway (Malaysia) Holdings Berhad reported sales of 966.33 million Malaysian Ringgits (US$239.37 million)
for the
year ending
December of 2019.
This
represents
a
decrease of 0.6%
versus 2018, when the company's sales were 972.27 million Malaysian Ringgits.